{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-026905","form_type":"8-K","ticker":"AVTR","cik":"0001722482","company_name":"Avantor, Inc.","filed_at":"2026-04-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.808388+00:00","generated_at":"2026-05-15T04:35:27.368194+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Avantor names Ludovic Brellier EVP Bioscience & Medtech Products; Gourdier to depart by Dec 2026","bullets":["Ludovic Brellier appointed EVP, Bioscience & Medtech Products and Chief Transformation Officer effective May 1, 2026.","Brellier joins from Danaher, where he was President of Cytiva’s Hardware Solutions; will lead Revival Management Office.","Current EVP Benoit Gourdier will transition to a support role and depart Avantor no later than December 31, 2026.","Brellier to oversee BMP business growth, operational performance, and enterprise transformation initiatives."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-026905","json":"https://secwatch.observer/filing/0001628280-26-026905.json","markdown":"https://secwatch.observer/filing/0001628280-26-026905.md","text":"https://secwatch.observer/filing/0001628280-26-026905.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1722482/000162828026026905/0001628280-26-026905-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1722482/000162828026026905/avtr-20260417.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T04:35:27.368194+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}